Huang, Yinan
Aparasu, Rajender R
Varisco, Tyler J
Article History
Received: 4 April 2023
Accepted: 16 June 2023
First Online: 1 August 2023
Declarations
:
: This study received IRB approval from University of Houston.
: Not Applicable (NA).
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Dr. Aparasu reports grants from Astellas, Incyte, and Novartis, outside the submitted work. Dr. Varisco receives research funding from the Foundation for Opioid Response Efforts and provides research consulting services to HEALIX Infusion Therapy. The remaining authors report no conflicts of interest.